| Year |
Citation |
Score |
| 2024 |
Juraschek SP, Cortez MM, Flack JM, Ghazi L, Kenny RA, Rahman M, Spikes T, Shibao CA, Biaggioni I. Orthostatic Hypotension in Adults With Hypertension: A Scientific Statement From the American Heart Association. Hypertension (Dallas, Tex. : 1979). PMID 38205630 DOI: 10.1161/HYP.0000000000000236 |
0.403 |
|
| 2023 |
Flack JM, Bitner S, Buhnerkempe M. Highlighting Important (Sel ected) Issues in Hypertension Therapeutics. Trends in Cardiovascular Medicine. PMID 38092265 DOI: 10.1016/j.tcm.2023.12.001 |
0.304 |
|
| 2023 |
Whelton PK, Flack JM, Jennings GLR, Schutte AE, Wang JG, Touyz RM. Editors' Commentary on the 2023 ESH Management of Arterial Hypertension Guidelines. Hypertension (Dallas, Tex. : 1979). PMID 37354199 DOI: 10.1161/HYPERTENSIONAHA.123.21592 |
0.303 |
|
| 2023 |
Azizi M, Saxena M, Wang Y, Jenkins JS, Devireddy C, Rader F, Fisher NDL, Schmieder RE, Mahfoud F, Lindsey J, Sanghvi K, Todoran TM, Pacella J, Flack J, Daemen J, et al. Endovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical Trial. Jama. 329: 651-661. PMID 36853250 DOI: 10.1001/jama.2023.0713 |
0.348 |
|
| 2022 |
Schlaich MP, Bellet M, Weber MA, Danaietash P, Bakris GL, Flack JM, Dreier RF, Sassi-Sayadi M, Haskell LP, Narkiewicz K, Wang JG. Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial. Lancet (London, England). PMID 36356632 DOI: 10.1016/S0140-6736(22)02034-7 |
0.345 |
|
| 2022 |
Bhandari P, Prakash V, Flack JM. Influence of Obesity on Blood Pressure Responses to Antihypertensive Drug Therapy in an Urban Hypertension Specialty Clinic. American Journal of Hypertension. 35: 740-744. PMID 35704857 DOI: 10.1093/ajh/hpac072 |
0.314 |
|
| 2021 |
A Romero C, Mathew S, Wasinski B, Reed B, Brody A, Dawood R, Twiner MJ, McNaughton CD, Fridman R, Flack JM, Carretero OA, Levy PD. Angiotensin-converting enzyme inhibitors increase anti-fibrotic biomarkers in African Americans with left ventricular hypertrophy. Journal of Clinical Hypertension (Greenwich, Conn.). PMID 33694311 DOI: 10.1111/jch.14206 |
0.323 |
|
| 2020 |
Levy PD, Burla MJ, Twiner M, Marinica AL, Mahn JJ, Reed B, Brody A, Ehrman R, Brodsky A, Zhang Y, Nasser SA, Flack JM. EFFECT OF LOWER BLOOD PRESSURE GOALS ON LEFT VENTRICULAR STRUCTURE AND FUNCTION IN PATIENTS WITH SUBCLINICAL HYPERTENSIVE HEART DISEASE. American Journal of Hypertension. PMID 32622346 DOI: 10.1093/Ajh/Hpaa108 |
0.728 |
|
| 2020 |
Schiffrin EL, Flack J, Ito S, Muntner P, Webb C. Hypertension and COVID-19. American Journal of Hypertension. PMID 32251498 DOI: 10.1093/Ajh/Hpaa057 |
0.456 |
|
| 2020 |
Buhnerkempe M, Prakash V, Botchway A, Adekola O, Flack JM. Abstract P179: The Magnitude, And Not Direction, Of Blood Pressure Change Influences The Risk Of Serious Adverse Events In SPRINT Hypertension. 76. DOI: 10.1161/Hyp.76.Suppl_1.P179 |
0.379 |
|
| 2019 |
Flack JM, Adekola B. Blood pressure and the new ACC/AHA hypertension guidelines. Trends in Cardiovascular Medicine. PMID 31521481 DOI: 10.1016/J.Tcm.2019.05.003 |
0.493 |
|
| 2019 |
Flack JM, Calhoun D. The ACC/AHA and ESC/ESH Hypertension Guidelines: Contrasting Versions of Idiosyncratic Excellence. American Journal of Hypertension. 32: 705-708. PMID 31314900 DOI: 10.1093/Ajh/Hpz092 |
0.423 |
|
| 2019 |
Buhnerkempe MG, Botchway A, Prakash V, Al-Akchar M, Nolasco Morales CE, Calhoun DA, Flack JM. Prevalence of refractory hypertension in the United States from 1999 to 2014. Journal of Hypertension. PMID 31058798 DOI: 10.1097/Hjh.0000000000002103 |
0.421 |
|
| 2019 |
Prakash V, Buhnerkempe MG, Botchway A, Adekola B, Al-Akchar M, Flack JM. Abstract P2070: Renal, Cardiovascular, And Mortality Impacts Of Refractory Hypertension In Patients With Chronic Kidney Disease: Insights From The Chronic Renal Insufficiency Cohort (CRIC). Hypertension. 74. DOI: 10.1161/Hyp.74.Suppl_1.P2070 |
0.356 |
|
| 2019 |
Botchway A, Buhnerkempe MG, Prakash V, Al-Akchar M, Adekola O, Flack JM. Abstract P2054: Experiencing the Primary Composite Cardiovascular Outcome is More Strongly Associated With Serious Adverse Events Than Intensive Treatment in the Systolic Blood Pressure Intervention Trial Hypertension. 74. DOI: 10.1161/Hyp.74.Suppl_1.P2054 |
0.384 |
|
| 2018 |
Calhoun DA, Schiffrin EL, Flack JM. Resistant Hypertension: An Update. American Journal of Hypertension. PMID 30407514 DOI: 10.1093/Ajh/Hpy156 |
0.351 |
|
| 2018 |
Buhnerkempe MG, Botchway A, Nolasco Morales CE, Prakash V, Hedquist L, Flack JM. Predicting the risk of apparent treatment-resistant hypertension: a longitudinal, cohort study in an urban hypertension referral clinic. Journal of the American Society of Hypertension : Jash. PMID 30392848 DOI: 10.1016/J.Jash.2018.09.006 |
0.443 |
|
| 2018 |
Carey RM, Calhoun DA, Bakris GL, Brook RD, Daugherty SL, Dennison-Himmelfarb CR, Egan BM, Flack JM, Gidding SS, Judd E, Lackland DT, Laffer CL, Newton-Cheh C, Smith SM, Taler SJ, et al. Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association. Hypertension (Dallas, Tex. : 1979). 72: e53-e90. PMID 30354828 DOI: 10.1161/Hyp.0000000000000084 |
0.453 |
|
| 2018 |
Egan B, Flack J, Patel M, Lombera S. Insights on β-blockers for the treatment of hypertension: A survey of health care practitioners. Journal of Clinical Hypertension (Greenwich, Conn.). PMID 30289609 DOI: 10.1111/Jch.13375 |
0.312 |
|
| 2018 |
Buhnerkempe M, Botchway A, Nolasco Morales CE, Prakash V, Flack JM. Abstract P368: Predicting the Risk of Refractory Hypertension Hypertension. 72. DOI: 10.1161/Hyp.72.Suppl_1.P368 |
0.472 |
|
| 2018 |
Buhnerkempe M, Botchway A, Nolasco Morales CE, Prakash V, Flack JM. Abstract P302: Prevalence of refractory hypertension in the United States from 1999-2014 Hypertension. 72. DOI: 10.1161/Hyp.72.Suppl_1.P302 |
0.337 |
|
| 2018 |
Romero CA, Reed B, Mathew S, Brodi A, Dawood R, Twiner M, McNaughton C, Flack JM, Carretero OA, Levy PD. Abstract P213: Angiotensin Converting Enzyme Inhibitors (ACEi) Increase Antifibrotic Biomarkers in African American Patients With Hypertension and Left Ventricular Hypertrophy Hypertension. 72. DOI: 10.1161/Hyp.72.Suppl_1.P213 |
0.455 |
|
| 2017 |
Flack JM, Calhoun D, Schiffrin EL. The New ACC/AHA Hypertension Guidelines for the prevention, detection, evaluation, and management of high blood pressure in adults. American Journal of Hypertension. PMID 29228096 DOI: 10.1093/Ajh/Hpx207 |
0.416 |
|
| 2017 |
Flack JM. Method of Blood Pressure Measurement, Interpretation of SPRINT, and the Atlantic Divide. Current Hypertension Reports. 19: 19. PMID 28271417 DOI: 10.1007/S11906-017-0719-0 |
0.375 |
|
| 2017 |
Flack JM. The emerging case for (much) lower than conventional (<140/90 mm Hg) blood pressure targets in hypertension treatment Journal of Clinical & Experimental Cardiology. 8. DOI: 10.4172/2155-9880-C1-073 |
0.333 |
|
| 2016 |
Levy PD, Willock RJ, Burla M, Brody A, Mahn J, Marinica A, Nasser SA, Flack JM. Total antihypertensive therapeutic intensity score and its relationship to blood pressure reduction. Journal of the American Society of Hypertension : Jash. PMID 27856202 DOI: 10.1016/J.Jash.2016.10.005 |
0.721 |
|
| 2016 |
Twiner MJ, Marinica AL, Kuper K, Goodman A, Mahn JJ, Burla MJ, Brody AM, Carroll JA, Josiah Willock R, Flack JM, Nasser SA, Levy P. Screening and Treatment for Subclinical Hypertensive Heart Disease in Emergency Department Patients With Uncontrolled Blood Pressure: A Cost Effectiveness Analysis. Academic Emergency Medicine : Official Journal of the Society For Academic Emergency Medicine. PMID 27797437 DOI: 10.1111/Acem.13122 |
0.713 |
|
| 2016 |
Flack JM. A Novel Approach for Estimating Cost-Effectiveness of Pharmacological Treatment in Drug Naïve Adults with Hypertension. American Journal of Hypertension. PMID 27585565 DOI: 10.1093/Ajh/Hpw090 |
0.312 |
|
| 2016 |
Flack JM, Nolasco C, Levy P. The Case for Low Blood Pressure Targets. American Journal of Hypertension. PMID 27572960 DOI: 10.1093/Ajh/Hpw087 |
0.477 |
|
| 2016 |
Schiffrin EL, Calhoun DA, Flack JM. Do We Need a New Definition of Hypertension After SPRINT? American Journal of Hypertension. PMID 27334926 DOI: 10.1093/Ajh/Hpw068 |
0.396 |
|
| 2016 |
Lash JP, Ricardo AC, Roy J, Deo R, Fischer M, Flack J, He J, Keane M, Lora C, Ojo A, Rahman M, Steigerwalt S, Tao K, Wolf M, Wright JT, et al. Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 27209443 DOI: 10.1053/J.Ajkd.2016.03.429 |
0.369 |
|
| 2016 |
Kario K, Bhatt DL, Kandzari DE, Brar S, Flack JM, Gilbert C, Oparil S, Robbins M, Townsend RR, Bakris G. Impact of Renal Denervation on Patients With Obstructive Sleep Apnea and Resistant Hypertension - Insights From the SYMPLICITY HTN-3 Trial. Circulation Journal : Official Journal of the Japanese Circulation Society. PMID 27118620 DOI: 10.1253/Circj.Cj-16-0035 |
0.343 |
|
| 2016 |
Flack JM, Moser LR, Lipari M, Petrovitch E, Farber M. In response to "as-needed intravenous antihypertensive therapy and blood pressure control". Journal of Hospital Medicine. PMID 26918782 DOI: 10.1002/Jhm.2565 |
0.396 |
|
| 2016 |
Gutiérrez OM, Parsa A, Isakova T, Scialla JJ, Chen J, Flack JM, Nessel LC, Gupta J, Bellovich KA, Steigerwalt S, Sondheimer JH, Wright JT, Feldman HI, Kusek JW, Lash JP, et al. Genetic African Ancestry and Markers of Mineral Metabolism in CKD. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 26912553 DOI: 10.2215/Cjn.08020715 |
0.349 |
|
| 2016 |
Schiffrin EL, Calhoun DA, Flack JM, Ito S, Webb RC. A Message From the New Editorial Team at the American Journal of Hypertension. American Journal of Hypertension. 29: 1. PMID 26658829 DOI: 10.1093/Ajh/Hpv173 |
0.393 |
|
| 2016 |
Schiffrin EL, Calhoun DA, Flack JM. SPRINT Proves that Lower Is Better for Nondiabetic High-Risk Patients, but at a Price. American Journal of Hypertension. 29: 2-4. PMID 26597221 DOI: 10.1093/Ajh/Hpv190 |
0.413 |
|
| 2015 |
Thomas G, Xie D, Chen HY, Anderson AH, Appel LJ, Bodana S, Brecklin CS, Drawz P, Flack JM, Miller ER, Steigerwalt SP, Townsend RR, Weir MR, Wright JT, Rahman M. Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study. Hypertension. PMID 26711738 DOI: 10.1161/Hypertensionaha.115.06487 |
0.454 |
|
| 2015 |
Lipari M, Moser LR, Petrovitch EA, Farber M, Flack JM. As-needed intravenous antihypertensive therapy and blood pressure control. Journal of Hospital Medicine. PMID 26560085 DOI: 10.1002/Jhm.2510 |
0.406 |
|
| 2015 |
Navaneethan SD, Roy J, Tao K, Brecklin CS, Chen J, Deo R, Flack JM, Ojo AO, Plappert TJ, Raj DS, Saydain G, Sondheimer JH, Sood R, Steigerwalt SP, Townsend RR, et al. Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in CKD. Journal of the American Society of Nephrology : Jasn. PMID 26386072 DOI: 10.1681/Asn.2014111111 |
0.358 |
|
| 2015 |
Flack JM, Bhatt DL, Kandzari DE, Brown D, Brar S, Choi JW, D'Agostino R, East C, Katzen BT, Lee L, Leon MB, Mauri L, O'Neill WW, Oparil S, Rocha-Singh K, et al. An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trial. Journal of the American Society of Hypertension : Jash. PMID 26362830 DOI: 10.1016/J.Jash.2015.08.001 |
0.429 |
|
| 2015 |
Denker M, Boyle S, Anderson AH, Appel LJ, Chen J, Fink JC, Flack J, Go AS, Horwitz E, Hsu CY, Kusek JW, Lash JP, Navaneethan S, Ojo AO, Rahman M, et al. Chronic Renal Insufficiency Cohort Study (CRIC): Overview and Summary of Selected Findings. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 26265715 DOI: 10.2215/Cjn.04260415 |
0.353 |
|
| 2015 |
Levy PD, Mahn JJ, Miller J, Shelby A, Brody A, Davidson R, Burla MJ, Marinica A, Carroll J, Purakal J, Flack JM, Welch RD. Blood pressure treatment and outcomes in hypertensive patients without acute target organ damage: a retrospective cohort. The American Journal of Emergency Medicine. PMID 26087706 DOI: 10.1016/J.Ajem.2015.05.036 |
0.409 |
|
| 2015 |
Brody A, Rahman T, Reed B, Millis S, Ference B, Flack JM, Levy PD. Safety and efficacy of antihypertensive prescription at emergency department discharge. Academic Emergency Medicine : Official Journal of the Society For Academic Emergency Medicine. 22: 632-5. PMID 25904073 DOI: 10.1111/Acem.12660 |
0.43 |
|
| 2015 |
Bakris GL, Townsend RR, Flack JM, Brar S, Cohen SA, D'Agostino R, Kandzari DE, Katzen BT, Leon MB, Mauri L, Negoita M, O'Neill WW, Oparil S, Rocha-Singh K, Bhatt DL, et al. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial. Journal of the American College of Cardiology. 65: 1314-21. PMID 25835443 DOI: 10.1016/J.Jacc.2015.01.037 |
0.42 |
|
| 2015 |
Kandzari DE, Bhatt DL, Brar S, Devireddy CM, Esler M, Fahy M, Flack JM, Katzen BT, Lea J, Lee DP, Leon MB, Ma A, Massaro J, Mauri L, Oparil S, et al. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. European Heart Journal. 36: 219-27. PMID 25400162 DOI: 10.1093/Eurheartj/Ehu441 |
0.419 |
|
| 2015 |
Flack JM, Ference BA, Levy P. Hypertension in African Americans Hypertension in High Risk African Americans: Current Concepts, Evidence-Based Therapeutics and Future Considerations. 233-249. DOI: 10.1007/978-1-4939-2010-5_15 |
0.327 |
|
| 2014 |
Purakal JD, Williams-Johnson J, Williams EW, Pemba S, Kambona J, Welch R, Flack J, Levy P. Differences and similarities in explanatory models of hypertension in the United States of america, Tanzania and Jamaica. The West Indian Medical Journal. 63: 238-46. PMID 25314281 DOI: 10.7727/Wimj.2013.302 |
0.357 |
|
| 2014 |
Brody AM, Murphy E, Flack JM, Levy PD. Primary care in the emergency department -- an untapped resource for public health research and innovation. The West Indian Medical Journal. 63: 234-7. PMID 25314280 DOI: 10.7727/Wimj.2013.332 |
0.302 |
|
| 2014 |
Mahn JJ, Dubey E, Brody A, Welch R, Zalenski R, Flack JM, Ference B, Levy PD. Test characteristics of electrocardiography for detection of left ventricular hypertrophy in asymptomatic emergency department patients with hypertension. Academic Emergency Medicine : Official Journal of the Society For Academic Emergency Medicine. 21: 996-1002. PMID 25269580 DOI: 10.1111/Acem.12462 |
0.306 |
|
| 2014 |
Brody AM, Flack JM, Ference BA, Levy PD. Utility of Framingham risk score in urban emergency department patients with asymptomatic hypertension. Critical Pathways in Cardiology. 13: 114-6. PMID 25062396 DOI: 10.1097/Hpc.0000000000000016 |
0.407 |
|
| 2014 |
Vemulapalli S, Ard J, Bakris GL, Bhatt DL, Brown AS, Cushman WC, Ferdinand KC, Flack JM, Fleg JL, Katzen BT, Kostis JB, Oparil S, Patel CB, Pepine CJ, Piña IL, et al. Proceedings from Duke resistant hypertension think tank. American Heart Journal. 167: 775-88.e1. PMID 24890525 DOI: 10.1016/J.Ahj.2014.02.008 |
0.433 |
|
| 2014 |
Bakris GL, Townsend RR, Liu M, Cohen SA, D'Agostino R, Flack JM, Kandzari DE, Katzen BT, Leon MB, Mauri L, Negoita M, O'Neill WW, Oparil S, Rocha-Singh K, Bhatt DL, et al. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3. Journal of the American College of Cardiology. 64: 1071-8. PMID 24858423 DOI: 10.1016/J.Jacc.2014.05.012 |
0.401 |
|
| 2014 |
Burla MJ, Brody AM, Ference BA, Flack JM, Mahn JJ, Marinica AL, Carroll JA, Nasser SA, Zhang S, Levy PD. Blood pressure control and perceived health status in African Americans with subclinical hypertensive heart disease. Journal of the American Society of Hypertension : Jash. 8: 321-9. PMID 24726098 DOI: 10.1016/J.Jash.2014.02.010 |
0.732 |
|
| 2014 |
Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL, et al. A controlled trial of renal denervation for resistant hypertension. The New England Journal of Medicine. 370: 1393-401. PMID 24678939 DOI: 10.1056/Nejmoa1402670 |
0.379 |
|
| 2014 |
Ference BA, Julius S, Mahajan N, Levy PD, Williams KA, Flack JM. Clinical effect of naturally random allocation to lower systolic blood pressure beginning before the development of hypertension. Hypertension. 63: 1182-8. PMID 24591335 DOI: 10.1161/Hypertensionaha.113.02734 |
0.415 |
|
| 2014 |
Flack JM, Ference BA, Levy P. Should African Americans with hypertension be treated differently than non-African Americans? Current Hypertension Reports. 16: 409. PMID 24370966 DOI: 10.1007/S11906-013-0409-5 |
0.515 |
|
| 2014 |
Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, Flack JM, Carter BL, Materson BJ, Ram CV, Cohen DL, Cadet JC, Jean-Charles RR, Taler S, Kountz D, et al. Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. Journal of Clinical Hypertension (Greenwich, Conn.). 16: 14-26. PMID 24341872 DOI: 10.1111/Jch.12237 |
0.407 |
|
| 2014 |
Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, Flack JM, Carter BL, Materson BJ, Ram CV, Cohen DL, Cadet JC, Jean-Charles RR, Taler S, Kountz D, et al. Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. Journal of Hypertension. 32: 3-15. PMID 24270181 DOI: 10.1097/Hjh.0000000000000065 |
0.407 |
|
| 2014 |
Bakris G, Townsend R, Flack J, Kandzari D, O'Neill W, D'Agostino R, Katzen B, Leon M, Liu M, Mauri L, Negoita M, Cohen S, Oparil S, Rocha-Singh K, Bhatt D. Ambulatory blood pressure results of symplicity HTN-3 trial Journal of the American Society of Hypertension. 8: e1. DOI: 10.1016/J.Jash.2014.07.008 |
0.402 |
|
| 2014 |
Brody A, Burla MJ, Marinica AL, Ference BA, Mahn JJ, Carroll JA, Nasser SA, Reed BA, Zhang S, Flack JM, Levy PD. Therapeutic intensity score as a novel measure for anti-hypertensive therapy Journal of the American Society of Hypertension. 8: e62-e63. DOI: 10.1016/J.Jash.2014.03.141 |
0.661 |
|
| 2014 |
King-Medina KN, Hedquist L, Levy P, Ference B, Flack JM. Predicting the development of resistant hypertension with non-invasive hemodynamic measures Journal of the American Society of Hypertension. 8: e38-e39. DOI: 10.1016/J.Jash.2014.03.077 |
0.32 |
|
| 2013 |
Ference BA, Mahajan N, Julius S, Yoo W, Okwuosa T, Afonso L, Levy P, Williams K, Flack J. EFFECT OF NATURALLY RANDOM ALLOCATION TO LOWER BLOOD PRESSURE BEGINNING BEFORE THE DEVELOPMENT OF HYPERTENSION Journal of the American College of Cardiology. 61: E1383. DOI: 10.1016/S0735-1097(13)61383-2 |
0.462 |
|
| 2012 |
Levy PD, Flack JM. Should African-Americans with elevated blood pressure be routinely screened for hypertensive heart disease? Expert Review of Cardiovascular Therapy. 10: 1201-4. PMID 23190057 DOI: 10.1586/Erc.12.130 |
0.476 |
|
| 2012 |
Flack JM, Okwuosa T, Sudhakar R, Ference B, Levy P. Should African Americans have a lower blood pressure goal than other ethnic groups to prevent organ damage? Current Cardiology Reports. 14: 660-6. PMID 23065361 DOI: 10.1007/S11886-012-0314-6 |
0.514 |
|
| 2012 |
Valiña-Tóth AL, Lai Z, Zhang S, Flack JM. Vitamin D and Parathyroid Hormone Relationships with Urinary Nitric Oxide Metabolites and Plasma Isoprostanes in African-Americans. Cardiorenal Medicine. 2: 234-242. PMID 22969780 DOI: 10.1159/000339942 |
0.741 |
|
| 2012 |
Bakhtar O, Ference BA, Hedquist LA, Levy PD, Flack JM. Relationship of resistant hypertension and treatment outcomes with total arterial compliance in a predominantly African American hypertensive cohort. Journal of Clinical Hypertension (Greenwich, Conn.). 14: 618-22. PMID 22947360 DOI: 10.1111/J.1751-7176.2012.00653.X |
0.489 |
|
| 2012 |
Feldman RD, Flack J, Howes L, Jenssen T, Reeves R, Shi H, Westergaard M, Hobbs FD. Impact of age and gender on blood pressure and low-density lipoprotein cholesterol reduction: results of a pooled analysis. Current Medical Research and Opinion. 28: 1421-33. PMID 22809114 DOI: 10.1185/03007995.2012.713339 |
0.391 |
|
| 2012 |
Flack JM, Graff A, Li W, Chavanu KJ. Efficacy/safety of olmesartan medoxomil versus losartan potassium in patients by stage 1 or 2 hypertension. Postgraduate Medicine. 124: 59-70. PMID 22691900 DOI: 10.3810/Pgm.2012.05.2549 |
0.406 |
|
| 2012 |
Levy P, Ye H, Compton S, Zalenski R, Byrnes T, Flack JM, Welch R. Subclinical hypertensive heart disease in black patients with elevated blood pressure in an inner-city emergency department. Annals of Emergency Medicine. 60: 467-74.e1. PMID 22658278 DOI: 10.1016/J.Annemergmed.2012.03.030 |
0.48 |
|
| 2012 |
Kandzari DE, Bhatt DL, Sobotka PA, O'Neill WW, Esler M, Flack JM, Katzen BT, Leon MB, Massaro JM, Negoita M, Oparil S, Rocha-Singh K, Straley C, Townsend RR, Bakris G. Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial. Clinical Cardiology. 35: 528-35. PMID 22573363 DOI: 10.1002/Clc.22008 |
0.462 |
|
| 2012 |
Flack JM, Yadao AM, Purkayastha D, Samuel R, White WB. Comparison of the effects of aliskiren/valsartan in combination versus valsartan alone in patients with stage 2 hypertension. Journal of the American Society of Hypertension : Jash. 6: 142-51. PMID 22321963 DOI: 10.1016/J.Jash.2011.11.004 |
0.449 |
|
| 2012 |
Flack JM, Nasser SA, Singh MM, Levy P, Crook ED. Hypertension in African Americans Hypertension: a Companion to Braunwald's Heart Disease: Second Edition. 356-364. DOI: 10.1016/B978-1-4377-2766-1.00040-5 |
0.688 |
|
| 2011 |
Flack JM, Nasser SA. Benefits of once-daily therapies in the treatment of hypertension. Vascular Health and Risk Management. 7: 777-87. PMID 22241952 DOI: 10.2147/Vhrm.S17207 |
0.72 |
|
| 2011 |
Grimm RH, Flack JM. Alpha 1 adrenoreceptor antagonists. Journal of Clinical Hypertension (Greenwich, Conn.). 13: 654-7. PMID 21896145 DOI: 10.1111/J.1751-7176.2011.00510.X |
0.333 |
|
| 2011 |
Flack JM, Nasser SA, Levy PD. Initial treatment of hypertension with aliskiren and amlodipine combination gives 6.5 mm Hg greater reduction in systolic BP than does either monotherapy. Evidence-Based Medicine. 16: 148-9. PMID 21856641 DOI: 10.1136/Ebm1308 |
0.693 |
|
| 2011 |
Afonso L, Bandaru H, Rathod A, Badheka A, Ali Kizilbash M, Zmily H, Jacobsen G, Chattahi J, Mohamad T, Koneru J, Flack J, Weaver WD. Prevalence, determinants, and clinical significance of cardiac troponin-I elevation in individuals admitted for a hypertensive emergency. Journal of Clinical Hypertension (Greenwich, Conn.). 13: 551-6. PMID 21806764 DOI: 10.1111/J.1751-7176.2011.00476.X |
0.356 |
|
| 2011 |
Taha W, Singh N, Flack JM, Abou-Samra AB. Low urine calcium excretion in African American patients with primary hyperparathyroidism. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 17: 867-72. PMID 21613053 DOI: 10.4158/Ep11022.Or |
0.32 |
|
| 2011 |
Flack JM, Nasser SA, Levy PD. Therapy of hypertension in African Americans. American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions. 11: 83-92. PMID 21446775 DOI: 10.2165/11586930-000000000-00000 |
0.739 |
|
| 2011 |
Mitchell JE, Ferdinand KC, Watson KE, Wenger NK, Watkins LO, Flack JM, Gavin JR, Reed JW, Saunders E, Wright JT. Treatment of heart failure in African Americans--a call to action. Journal of the National Medical Association. 103: 86-98. PMID 21443060 DOI: 10.1016/S0027-9684(15)30257-1 |
0.345 |
|
| 2011 |
Flack JM, Sica DA, Nesbitt S. Chlorthalidone versus hydrochlorothiazide as the preferred diuretic: is there a verdict yet? Hypertension. 57: 665-6. PMID 21383308 DOI: 10.1161/Hypertensionaha.110.164566 |
0.419 |
|
| 2011 |
Weir MR, Punzi HA, Flack JM, Stoakes KA, Chavanu KJ, Li W, Dubiel R. A randomized, double-blind, forced-titration study to compare olmesartan medoxomil versus losartan potassium in patients with stage 1 and 2 hypertension. Postgraduate Medicine. 123: 80-7. PMID 21293087 DOI: 10.3810/Pgm.2011.01.2248 |
0.388 |
|
| 2011 |
Levy P, Shelby A, Davidson R, Mahn J, Marinica A, Carroll J, Purakal J, Medado P, Flack J, Welch R. 183 Acute Blood Pressure Reduction and Outcomes in Asymptomatic Hypertension: A Retrospective Cohort Study Annals of Emergency Medicine. 58: S238-S239. DOI: 10.1016/J.Annemergmed.2011.06.211 |
0.432 |
|
| 2010 |
Flack JM, Ferdinand KC, Nasser SA, Rossi NF. Hypertension in special populations: chronic kidney disease, organ transplant recipients, pregnancy, autonomic dysfunction, racial and ethnic populations. Cardiology Clinics. 28: 623-38. PMID 20937446 DOI: 10.1016/J.Ccl.2010.07.007 |
0.719 |
|
| 2010 |
Flack JM. Effect of combining extended-release carvedilol and lisinopril in hypertension: results of the COSMOS study. Journal of Clinical Hypertension (Greenwich, Conn.). 12: 664-5. PMID 20928961 DOI: 10.1111/J.1751-7176.2010.00351.X |
0.414 |
|
| 2010 |
Flack JM, Sica DA, Bakris G, Brown AL, Ferdinand KC, Grimm RH, Hall WD, Jones WE, Kountz DS, Lea JP, Nasser S, Nesbitt SD, Saunders E, Scisney-Matlock M, Jamerson KA, et al. Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension. 56: 780-800. PMID 20921433 DOI: 10.1161/Hypertensionaha.110.152892 |
0.757 |
|
| 2010 |
Ferrario CM, Flack JM, Strobeck JE, Smits G, Peters C. Individualizing hypertension treatment with impedance cardiography: a meta-analysis of published trials. Therapeutic Advances in Cardiovascular Disease. 4: 5-16. PMID 20042450 DOI: 10.1177/1753944709348236 |
0.492 |
|
| 2010 |
Townsend RR, Wimmer NJ, Chirinos JA, Parsa A, Weir M, Perumal K, Lash JP, Chen J, Steigerwalt SP, Flack J, Go AS, Rafey M, Rahman M, Sheridan A, Gadegbeku CA, et al. Aortic PWV in chronic kidney disease: a CRIC ancillary study. American Journal of Hypertension. 23: 282-9. PMID 20019670 DOI: 10.1038/Ajh.2009.240 |
0.344 |
|
| 2009 |
Flack JM. Basic principles of effective hypertension therapeutics. Ethnicity & Disease. 19: S5-1-2. PMID 20073297 |
0.319 |
|
| 2009 |
Ferdinand KC, Flack JM, Saunders E, Victor R, Watson K, Kursun A, Jamieson MJ, Shi H. Amlodipine/Atorvastatin single-pill therapy for blood pressure and lipid goals in African Americans: influence of the metabolic syndrome and type 2 diabetes mellitus. Journal of Clinical Hypertension (Greenwich, Conn.). 11: 585-93. PMID 19817942 DOI: 10.1111/J.1751-7176.2009.00062.X |
0.397 |
|
| 2009 |
Flack JM, Hilkert R. Single-pill combination of amlodipine and valsartan in the management of hypertension. Expert Opinion On Pharmacotherapy. 10: 1979-94. PMID 19606937 DOI: 10.1517/14656560903120899 |
0.447 |
|
| 2009 |
Flack JM, Calhoun DA, Satlin L, Barbier M, Hilkert R, Brunel P. Efficacy and safety of initial combination therapy with amlodipine/valsartan compared with amlodipine monotherapy in black patients with stage 2 hypertension: the EX-STAND study. Journal of Human Hypertension. 23: 479-89. PMID 19190658 DOI: 10.1038/Jhh.2008.153 |
0.449 |
|
| 2008 |
Nasser SA, Lai Z, O'Connor S, Liu X, Flack JM. Does earlier attainment of blood pressure goal translate into fewer cardiovascular events? Current Hypertension Reports. 10: 398-404. PMID 18775119 DOI: 10.1007/S11906-008-0074-2 |
0.732 |
|
| 2008 |
Payne KA, Caro JJ, Daley WL, Khan ZM, Ishak KJ, Stark K, Purkayastha D, Flack J, Velázquez E, Nesbitt S, Morisky D, Califf R. The design of an observational study of hypertension management, adherence and pressure control in Blood Pressure Success Zone Program participants. International Journal of Clinical Practice. 62: 1313-21. PMID 18647193 DOI: 10.1111/J.1742-1241.2008.01840.X |
0.408 |
|
| 2008 |
Flack JM, Victor R, Watson K, Ferdinand KC, Saunders E, Tarasenko L, Jamieson MJ, Shi H, Bruschi P. Improved attainment of blood pressure and cholesterol goals using single-pill amlodipine/atorvastatin in African Americans: the CAPABLE trial. Mayo Clinic Proceedings. 83: 35-45. PMID 18174006 DOI: 10.4065/83.1.35 |
0.486 |
|
| 2008 |
Payne K, Ishak K, Caro J, Khan Z, Stark K, Flack J, Velazquez E, Nesbitt S, Califf R. Pcv8 Blood Pressure Success Zone Longitudinal Study Of Success (Bpsz-Bliss). An Observational, Multi-Center Study Of The Impact Of The Bpsz Educational Program On Blood Pressure Control, Persistence, Compliance, And Treatment Satisfaction. Enrollment Metrics And Baseline Cohort Characteristics Value in Health. 11. DOI: 10.1016/S1098-3015(10)70596-9 |
0.39 |
|
| 2008 |
Flack JM, Valina-Toth A, Nasser S. Is vitamin D an overlooked contributor to excess cardiovascular disease in blacks? Current Cardiovascular Risk Reports. 2: 245-246. DOI: 10.1007/S12170-008-0045-9 |
0.735 |
|
| 2008 |
Flack JM, Nasser SA, O'Connor SM. Underuse of antihypertensive therapies in at-risk populations Current Cardiovascular Risk Reports. 2: 192-197. DOI: 10.1007/S12170-008-0036-X |
0.732 |
|
| 2007 |
Flack JM, Duncan K, Ohmit SE, Quah R, Liu X, Ramappa P, Norris S, Hedquist L, Dudley A, Nasser SA. Influence of albuminuria and glomerular filtration rate on blood pressure response to antihypertensive drug therapy. Vascular Health and Risk Management. 3: 1029-37. PMID 18200821 |
0.714 |
|
| 2007 |
Flack JM. Epidemiology and unmet needs in hypertension. Journal of Managed Care Pharmacy : Jmcp. 13: 2-8. PMID 17970612 DOI: 10.18553/Jmcp.2007.13.S8-A.2 |
0.477 |
|
| 2007 |
Flack JM. Maximising antihypertensive effects of angiotensin II receptor blockers with thiazide diuretic combination therapy: focus on irbesartan/hydrochlorothiazide. International Journal of Clinical Practice. 61: 2093-102. PMID 17887997 DOI: 10.1111/J.1742-1241.2007.01577.X |
0.411 |
|
| 2007 |
Artinian NT, Flack JM, Nordstrom CK, Hockman EM, Washington OG, Jen KL, Fathy M. Effects of nurse-managed telemonitoring on blood pressure at 12-month follow-up among urban African Americans. Nursing Research. 56: 312-22. PMID 17846552 DOI: 10.1097/01.Nnr.0000289501.45284.6E |
0.468 |
|
| 2007 |
Basile J, Black HR, Flack JM, Izzo JL. The role of therapeutic inertia and the use of fixed-dose combination therapy in the management of hypertension. Journal of Clinical Hypertension (Greenwich, Conn.). 9: 636-45. PMID 17673886 DOI: 10.1111/J.1524-6175.2007.07180.X |
0.309 |
|
| 2007 |
Jen KL, Brogan K, Washington OG, Flack JM, Artinian NT. Poor nutrient intake and high obese rate in an urban African American population with hypertension. Journal of the American College of Nutrition. 26: 57-65. PMID 17353584 DOI: 10.1080/07315724.2007.10719586 |
0.37 |
|
| 2007 |
Flack JM. Editorial commentary on fixed combination isosorbide dinitrate/hydralazine for nitric-oxide-enhancing therapy in heart failure. Expert Opinion On Pharmacotherapy. 8: 275-7. PMID 17266462 DOI: 10.1517/14656566.8.3.275 |
0.334 |
|
| 2007 |
Flack JM, Atlas SA, Pool JL, White WB. Renin-Angiotensin Aldosterone System and Hypertension: Current Approaches and Future Directions Journal of Managed Care Pharmacy. 13: 1-39. DOI: 10.18553/Jmcp.2007.13.S8-B.1 |
0.381 |
|
| 2007 |
Payne K, Caro J, Daley W, Khan Z, Ishak K, Stark K, Flack J, Velázquez E, Nesbitt S, Califf R. Pcv69 Blood Pressure Success Zone Longitudinal Study Of Success (Bpsz-Bliss). An Observational, Multicenter Study Of The Impact Of The Bpsz Educational Program On Blood Pressure Control, Persistence, Compliance, And Treatment Satisfaction. Design And Methods Value in Health. 10. DOI: 10.1016/S1098-3015(10)68711-6 |
0.382 |
|
| 2007 |
Flack JM, Nasser SA, Britton M, Valina-Toth AB, Ahooja V, O'Connor SM. Hypertension in Racial and Ethnic Minorities Comprehensive Hypertension. 707-718. DOI: 10.1016/B978-0-323-03961-1.50060-X |
0.688 |
|
| 2006 |
Messerli FH, Bakris GL, Ferrera D, Houston MC, Petrella RJ, Flack JM, Sun W, Lee E, Neutel JM. Efficacy and safety of coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia: results of the AVALON trial. Journal of Clinical Hypertension (Greenwich, Conn.). 8: 571-81; quiz 582-3. PMID 16896273 DOI: 10.1111/J.1524-6175.2006.05636.X |
0.369 |
|
| 2006 |
Artinian NT, Washington OG, Flack JM, Hockman EM, Jen KL. Depression, stress, and blood pressure in urban African-American women. Progress in Cardiovascular Nursing. 21: 68-75. PMID 16760688 DOI: 10.1111/J.0889-7204.2006.04787.X |
0.379 |
|
| 2006 |
Flack JM. Noninvasive hemodynamic measurements: an important advance in individualizing drug therapies for hypertensive patients. Hypertension. 47: 646-7. PMID 16520406 DOI: 10.1161/01.Hyp.0000209579.56979.A0 |
0.43 |
|
| 2006 |
Clark R, Benkert RA, Flack JM. Violence exposure and optimism predict task-induced changes in blood pressure and pulse rate in a normotensive sample of inner-city black youth. Psychosomatic Medicine. 68: 73-9. PMID 16449414 DOI: 10.1097/01.Psy.0000195744.13608.11 |
0.362 |
|
| 2005 |
Weir MR, Ferdinand KC, Flack JM, Jamerson KA, Daley W, Zelenkofske S. A noninferiority comparison of valsartan/hydrochlorothiazide combination versus amlodipine in black hypertensives. Hypertension. 46: 508-13. PMID 16116046 DOI: 10.1161/01.Hyp.0000180457.82483.6B |
0.442 |
|
| 2005 |
Flack JM, Sica DA. Therapeutic considerations in the African-American patient with hypertension: considerations with calcium channel blocker therapy. Journal of Clinical Hypertension (Greenwich, Conn.). 7: 9-14. PMID 15858397 DOI: 10.1111/J.1524-6175.2006.04475.X |
0.492 |
|
| 2005 |
El-Achkar TM, Ohmit SE, McCullough PA, Crook ED, Brown WW, Grimm R, Bakris GL, Keane WF, Flack JM. Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program. Kidney International. 67: 1483-8. PMID 15780101 DOI: 10.1111/J.1523-1755.2005.00226.X |
0.308 |
|
| 2005 |
Benjamin EJ, Jessup M, Flack JM, Krumholz HM, Liu K, Nadkarni VM, Rhoades DA, Rodriguez BL, Scott RP, Taylor MP, Velazquez EJ, Winkleby MA. Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Outcomes Writing Group. Circulation. 111: e124-33. PMID 15769754 DOI: 10.1161/01.Cir.0000157742.95689.65 |
0.339 |
|
| 2005 |
McFarlane SI, Castro J, Kaur J, Shin JJ, Kelling D, Farag A, Simon N, El-Atat F, Sacerdote A, Basta E, Flack J, Bakris G, Sowers JR. Control of blood pressure and other cardiovascular risk factors at different practice settings: outcomes of care provided to diabetic women compared to men. Journal of Clinical Hypertension (Greenwich, Conn.). 7: 73-80. PMID 15722651 DOI: 10.1111/J.1524-6175.2005.03869.X |
0.401 |
|
| 2004 |
Mokwe E, Ohmit SE, Nasser SA, Shafi T, Saunders E, Crook E, Dudley A, Flack JM. Determinants of blood pressure response to quinapril in black and white hypertensive patients: the Quinapril Titration Interval Management Evaluation trial. Hypertension. 43: 1202-7. PMID 15117912 DOI: 10.1161/01.Hyp.0000127924.67353.86 |
0.717 |
|
| 2004 |
Peters RM, Flack JM. Hypertensive disorders of pregnancy. Journal of Obstetric, Gynecologic, and Neonatal Nursing : Jognn / Naacog. 33: 209-20. PMID 15095800 DOI: 10.1177/0884217504262970 |
0.311 |
|
| 2004 |
Flack J, Dingell JD, Houston M, Neutel J, Ferrera D, Gillen D, Gibson E. Efficacy And Safety Of Atorvastatin Plus Amlodipine Versus Either Agent Alone In Patients With Concomitant Dysupidemia And Hypertension: The Avalon Study Journal of Hypertension. 22. DOI: 10.1097/00004872-200402001-00036 |
0.347 |
|
| 2004 |
FLACK J. Health care costs related to multi-drug treated hypertensives in the medicare population American Journal of Hypertension. 17: S196-S197. DOI: 10.1016/J.Amjhyper.2004.03.519 |
0.384 |
|
| 2004 |
FLACK J. Safety and efficacy of combination ace inhibitor/calcium channel blocker therapy versus ace inhibitor monotherapy in african american patients with hypertension and type 2 diabetes American Journal of Hypertension. 17: S180-S181. DOI: 10.1016/J.Amjhyper.2004.03.475 |
0.354 |
|
| 2003 |
Brown WW, Peters RM, Ohmit SE, Keane WF, Collins A, Chen SC, King K, Klag MJ, Molony DA, Flack JM. Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP). American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 42: 22-35. PMID 12830453 DOI: 10.1016/S0272-6386(03)00405-0 |
0.437 |
|
| 2003 |
Ohmit SE, Flack JM, Peters RM, Brown WW, Grimm R. Longitudinal Study of the National Kidney Foundation's (NKF) Kidney Early Evaluation Program (KEEP). Journal of the American Society of Nephrology : Jasn. 14: S117-21. PMID 12819315 DOI: 10.1097/01.Asn.0000070155.63971.B2 |
0.312 |
|
| 2003 |
Flack JM, Peters R, Shafi T, Alrefai H, Nasser SA, Crook E. Prevention of hypertension and its complications: theoretical basis and guidelines for treatment. Journal of the American Society of Nephrology : Jasn. 14: S92-8. PMID 12819310 DOI: 10.1097/01.Asn.0000070142.14843.8E |
0.715 |
|
| 2003 |
Crook ED, Thallapureddy A, Migdal S, Flack JM, Greene EL, Salahudeen A, Tucker JK, Taylor HA. Lipid abnormalities and renal disease: is dyslipidemia a predictor of progression of renal disease? The American Journal of the Medical Sciences. 325: 340-8. PMID 12811230 DOI: 10.1097/00000441-200306000-00005 |
0.355 |
|
| 2003 |
Crook ED, Clark BL, Bradford ST, Golden K, Calvin R, Taylor HA, Flack JM. From 1960s Evans County Georgia to present-day Jackson, Mississippi: an exploration of the evolution of cardiovascular disease in African Americans. The American Journal of the Medical Sciences. 325: 307-14. PMID 12811227 DOI: 10.1097/00000441-200306000-00002 |
0.375 |
|
| 2003 |
Flack JM, Peters R, Mehra VC, Nasser SA. Hypertension in special populations. Current Problems in Cardiology. 28: 194-223. PMID 12806316 DOI: 10.1016/S0146-2806(03)00018-5 |
0.726 |
|
| 2003 |
Flack JM, Nasser SA. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Major outomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. Current Hypertension Reports. 5: 189-91. PMID 12724049 DOI: 10.1007/S11906-003-0019-8 |
0.688 |
|
| 2003 |
Flack JM, Oparil S, Pratt JH, Roniker B, Garthwaite S, Kleiman JH, Yang Y, Krause SL, Workman D, Saunders E. Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients. Journal of the American College of Cardiology. 41: 1148-55. PMID 12679215 DOI: 10.1016/S0735-1097(03)00054-8 |
0.462 |
|
| 2003 |
Peters RM, Flack JM. Diagnosis and treatment of hypertension in children and adolescents. Journal of the American Academy of Nurse Practitioners. 15: 56-63. PMID 12640940 DOI: 10.1111/J.1745-7599.2003.Tb00352.X |
0.309 |
|
| 2003 |
Douglas JG, Bakris GL, Epstein M, Ferdinand KC, Ferrario C, Flack JM, Jamerson KA, Jones WE, Haywood J, Maxey R, Ofili EO, Saunders E, Schiffrin EL, Sica DA, Sowers JR, et al. Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Archives of Internal Medicine. 163: 525-41. PMID 12622600 DOI: 10.1001/Archinte.163.5.525 |
0.502 |
|
| 2003 |
Flack JM, Ferdinand KC, Nasser SA. Epidemiology of hypertension and cardiovascular disease in African Americans. Journal of Clinical Hypertension (Greenwich, Conn.). 5: 5-11. PMID 12556667 DOI: 10.1111/J.1524-6175.2003.02152.X |
0.738 |
|
| 2002 |
Flack JM, Casciano R, Casciano J, Doyle J, Arikian S, Tang S, Arocho R. Cardiovascular disease costs associated with uncontrolled hypertension. Managed Care Interface. 15: 28-36. PMID 12449899 |
0.344 |
|
| 2002 |
Crook ED, Flack JM, Salem M, Salahudeen AK, Hall J. Primary renal disease as a cardiovascular risk factor. The American Journal of the Medical Sciences. 324: 138-45. PMID 12240711 DOI: 10.1097/00000441-200209000-00004 |
0.414 |
|
| 2002 |
Flack JM, Peters R, Mehra VC, Nasser SA. Hypertension in special populations. Cardiology Clinics. 20: 303-19, vii. PMID 12171025 DOI: 10.1016/S0733-8651(01)00006-6 |
0.707 |
|
| 2002 |
Flack JM. Effect of ramipril versus amlodipine on renal outcomes in hypertensive nephrosclerosis. Current Hypertension Reports. 4: 183-4. PMID 12003698 DOI: 10.1007/S11906-002-0004-7 |
0.356 |
|
| 2002 |
Kostis JB, Cobbe S, Johnston C, Ford I, Murphy M, Weber MA, Black HR, Plouin PF, Levy D, Mancia G, Larochelle P, Kolloch RE, Alderman M, Ruilope LM, Dahlöf B, ... Flack JM, et al. Design of the Omapatrilat in Persons with Enhanced Risk of Atherosclerotic events (OPERA) trial. American Journal of Hypertension. 15: 193-8. PMID 11863257 DOI: 10.1016/S0895-7061(01)02048-9 |
0.452 |
|
| 2001 |
Flack JM, Saunders E, Gradman A, Kraus WE, Lester FM, Pratt JH, Alderman M, Green S, Vargas R, Espenshade M, Ceesay P, Alexander J, Goldberg A. Antihypertensive efficacy and safety of losartan alone and in combination with hydrochlorothiazide in adult African Americans with mild to moderate hypertension. Clinical Therapeutics. 23: 1193-208. PMID 11558858 DOI: 10.1016/S0149-2918(01)80101-6 |
0.488 |
|
| 2001 |
Flack J. A multicenter single-blind trial evaluating the efficacy of amlodipine in patients with severe hypertension (JNC stage 3) American Journal of Hypertension. 14: A109-A110. DOI: 10.1016/S0895-7061(01)01432-7 |
0.35 |
|
| 2001 |
Flack JM, Ramappa P, Jones S, Alrefai H. Hypertension in the geriatric patient Infertility and Reproductive Medicine Clinics of North America. 12: 535-547. |
0.39 |
|
| 2000 |
Peters RM, Flack JM. Salt sensitivity and hypertension in African Americans: implications for cardiovascular nurses Progress in Cardiovascular Nursing. 15: 138-144. PMID 2001132386 |
0.305 |
|
| 2000 |
Peters RM, Flack JM. Salt sensitivity and hypertension in African Americans: implications for cardiovascular nurses. Progress in Cardiovascular Nursing. 15: 138-44. PMID 11098526 DOI: 10.1111/J.0889-7204.2000.080404.X |
0.419 |
|
| 2000 |
Flack JM, Mensah GA, Ferrario CM. Using angiotensin converting enzyme inhibitors in African-American hypertensives: a new approach to treating hypertension and preventing target-organ damage. Current Medical Research and Opinion. 16: 66-79. PMID 10893650 DOI: 10.1185/0300799009117011 |
0.432 |
|
| 2000 |
Flack JM, Yunis C, Preisser J, Holmes CB, Mensah G, McLean B, Saunders E. The rapidity of drug dose escalation influences blood pressure response and adverse effects burden in patients with hypertension: the Quinapril Titration Interval Management Evaluation (ATIME) Study. ATIME Research Group. Archives of Internal Medicine. 160: 1842-7. PMID 10871979 DOI: 10.1001/Archinte.160.12.1842 |
0.446 |
|
| 1999 |
Flack JM. Optimal blood pressure on antihypertensive medication. Current Hypertension Reports. 1: 381-6. PMID 10981094 DOI: 10.1007/S11906-999-0052-3 |
0.492 |
|
| 1999 |
Flack JM, Gardin JM, Yunis C, Liu K. Static and pulsatile blood pressure correlates of left ventricular structure and function in black and white young adults: the CARDIA study. American Heart Journal. 138: 856-64. PMID 10539816 DOI: 10.1016/S0002-8703(99)70010-4 |
0.403 |
|
| 1999 |
Raskin P, Guthrie R, Flack J, Reeves R, Saini R. The long-term antihypertensive activity and tolerability of irbesartan with hydrochlorothiazide. Journal of Human Hypertension. 13: 683-7. PMID 10516738 DOI: 10.1038/Sj.Jhh.1000888 |
0.416 |
|
| 1999 |
Flack JM, Hamaty M. Difficult-to-treat hypertensive populations: focus on African-Americans and people with type 2 diabetes. Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension. 17: S19-24. PMID 10340840 |
0.423 |
|
| 1999 |
Ganguli MC, Grimm RH, Svendsen KH, Flack JM, Grandits GA, Elmer PJ. Urinary sodium and potassium profile of blacks and whites in relation to education in two different geographic urban areas. TOMHS Research Group. Treatment of Mild Hypertension Study. American Journal of Hypertension. 12: 69-72. PMID 10075387 DOI: 10.1016/S0895-7061(98)00218-0 |
0.354 |
|
| 1999 |
Ferrario CM, Yunis C, Mendys P, Levy PJ, Flack JM, Dean RH. Control of hypertension and blood pressure in the southeast region of the United States: A call for action Cardiovascular Reviews and Reports. 20: 379-386. |
0.302 |
|
| 1998 |
Flack JM, Staffileno BA. Therapeutic strategies for hypertension treatment in patients with selected cardiovascular diseases. Drugs of Today (Barcelona, Spain : 1998). 34: 813-22. PMID 14988756 |
0.387 |
|
| 1998 |
Flack JM, Hamaty M, Staffileno BA. Renin-angiotensin-aldosterone-kinin system influences on diabetic vascular disease and cardiomyopathy. Mineral and Electrolyte Metabolism. 24: 412-22. PMID 9930381 DOI: 10.1159/000057403 |
0.352 |
|
| 1998 |
Hall WD, Reed JW, Flack JM, Yunis C, Preisser J. Comparison of the efficacy of dihydropyridine calcium channel blockers in African American patients with hypertension. ISHIB Investigators Group. International Society on Hypertension in Blacks. Archives of Internal Medicine. 158: 2029-34. PMID 9778203 DOI: 10.1001/Archinte.158.18.2029 |
0.388 |
|
| 1998 |
Ferrario CM, Martell N, Yunis C, Flack JM, Chappell MC, Brosnihan KB, Dean RH, Fernandez A, Novikov SV, Pinillas C, Luque M. Characterization of angiotensin-(1-7) in the urine of normal and essential hypertensive subjects. American Journal of Hypertension. 11: 137-46. PMID 9524041 DOI: 10.1016/S0895-7061(97)00400-7 |
0.422 |
|
| 1998 |
Staffileno BA, Braun LT, Flack JM. The Accumulative Effects Of Physical Activity In Hypertensive, Post-Menopausal Women Medicine and Science in Sports and Exercise. 30: 82. DOI: 10.1097/00005768-199805001-00470 |
0.322 |
|
| 1997 |
Larochelle P, Flack JM, Marbury TC, Sareli P, Krieger EM, Reeves RA. Effects and tolerability of irbesartan versus enalapril in patients with severe hypertension. Irbesartan Multicenter Investigators. The American Journal of Cardiology. 80: 1613-5. PMID 9416950 DOI: 10.1016/S0002-9149(97)00784-4 |
0.455 |
|
| 1997 |
Ganguli MC, Grimm RH, Svendsen KH, Flack JM, Grandits GA, Elmer PJ. Higher education and income are related to a better Na:K ratio in blacks: baseline results of the Treatment of Mild Hypertension Study (TOMHS) data. American Journal of Hypertension. 10: 979-84. PMID 9324102 DOI: 10.1016/S0895-7061(97)00162-3 |
0.336 |
|
| 1997 |
Weir MR, Hall PS, Behrens MT, Flack JM. Salt and blood pressure responses to calcium antagonism in hypertensive patients. Hypertension. 30: 422-7. PMID 9314427 DOI: 10.1161/01.Hyp.30.3.422 |
0.451 |
|
| 1997 |
Deitch JS, Hansen KJ, Craven TE, Flack JM, Appel RG, Dean RH. Renal artery repair in African-Americans. Journal of Vascular Surgery. 26: 465-72; discussion 4. PMID 9308592 DOI: 10.1016/S0741-5214(97)70039-9 |
0.343 |
|
| 1997 |
Flack JM. Living with hypertension. Introduction to dealing with elevated blood pressure. North Carolina Medical Journal. 58: 193-6. PMID 9164131 |
0.344 |
|
| 1997 |
Flack JM, Yunis C. Therapeutic implications of the epidemiology and timing of myocardial infarction and other cardiovascular diseases. Journal of Human Hypertension. 11: 23-8. PMID 9111153 DOI: 10.1038/Sj.Jhh.1000396 |
0.425 |
|
| 1997 |
Hall WD, Ferrario CM, Moore MA, Hall JE, Flack JM, Cooper W, Simmons JD, Egan BM, Lackland DT, Perry M, Roccella EJ. Hypertension-related morbidity and mortality in the southeastern United States. The American Journal of the Medical Sciences. 313: 195-209. PMID 9099149 DOI: 10.1016/S0002-9629(15)40095-3 |
0.412 |
|
| 1997 |
Grimm RH, Grandits GA, Prineas RJ, McDonald RH, Lewis CE, Flack JM, Yunis C, Svendsen K, Liebson PR, Elmer PJ. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS) Hypertension. 29: 8-14. PMID 9039073 DOI: 10.1161/01.HYP.29.1.8 |
0.343 |
|
| 1997 |
FLACK J. Optimal utilization of calcium antagonists in special hypertensive populations American Journal of Hypertension. 10: 239A. DOI: 10.1016/S0895-7061(97)89527-1 |
0.33 |
|
| 1997 |
FLACK J. Renovascular hypertension: Uncloaking the emperor American Journal of Hypertension. 10: 236A. DOI: 10.1016/S0895-7061(97)89519-2 |
0.457 |
|
| 1997 |
FLACK J. Cardiovascular diseases American Journal of Hypertension. 10: 227A. DOI: 10.1016/S0895-7061(97)89485-X |
0.321 |
|
| 1996 |
Ferrario CM, Flack JM. Pathologic consequences of increased angiotensin II activity. Cardiovascular Drugs and Therapy / Sponsored by the International Society of Cardiovascular Pharmacotherapy. 10: 511-8. PMID 8950064 DOI: 10.1007/Bf00050990 |
0.323 |
|
| 1996 |
Markovitz JH, Raczynski JM, Lewis CE, Flack J, Chesney M, Chettur V, Hardin JM, Johnson E. Lack of independent relationships between left ventricular mass and cardiovascular reactivity to physical and psychological stress in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. American Journal of Hypertension. 9: 915-23. PMID 8879349 DOI: 10.1016/S0895-7061(96)00149-5 |
0.385 |
|
| 1996 |
Weir MR, Flack JM, Applegate WB. Tolerability, safety, and quality of life and hypertensive therapy: the case for low-dose diuretics. The American Journal of Medicine. 101: 83S-92S. PMID 8876478 DOI: 10.1016/S0002-9343(96)00271-9 |
0.407 |
|
| 1996 |
Flack JM, Cushman WC. Evidence for the efficacy of low-dose diuretic monotherapy. The American Journal of Medicine. 101: 53S-60S. PMID 8876475 DOI: 10.1016/S0002-9343(96)00268-9 |
0.433 |
|
| 1996 |
Gidding SS, Liu K, Bild DE, Flack J, Gardin J, Ruth KJ, Oberman A. Prevalence and identification of abnormal lipoprotein levels in a biracial population aged 23 to 35 years (the CARDIA Study). The Coronary Artery Risk Development in Young Adults Study. The American Journal of Cardiology. 78: 304-8. PMID 8759809 DOI: 10.1016/S0002-9149(96)00282-2 |
0.311 |
|
| 1996 |
Flack JM, Novikov SV, Ferrario CM. Benefits of adherence to anti-hypertensive drug therapy. European Heart Journal. 17: 16-20. PMID 8737196 DOI: 10.1093/Eurheartj/17.Suppl_A.16 |
0.47 |
|
| 1996 |
Grimm RH, Flack JM, Schoenberger JA, Gonzalez NM, Liebson PR. Alpha-blockade and thiazide treatment of hypertension. A double-blind randomized trail comparing doxazosin and hydrochlorothiazide. American Journal of Hypertension. 9: 445-54. PMID 8735175 DOI: 10.1016/0895-7061(95)00439-4 |
0.39 |
|
| 1996 |
Grimm RH, Flack JM, Grandits GA, Elmer PJ, Neaton JD, Cutler JA, Lewis C, McDonald R, Schoenberger J, Stamler J. Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group. Jama. 275: 1549-56. PMID 8622245 DOI: 10.1001/Jama.1996.03530440029033 |
0.353 |
|
| 1996 |
Liu K, Ruth KJ, Flack JM, Jones-Webb R, Burke G, Savage PJ, Hulley SB. Blood pressure in young blacks and whites: relevance of obesity and lifestyle factors in determining differences. The CARDIA Study. Coronary Artery Risk Development in Young Adults. Circulation. 93: 60-6. PMID 8616942 DOI: 10.1161/01.Cir.93.1.60 |
0.412 |
|
| 1996 |
Lewis CE, Grandits GA, Flack J, McDonald R, Elmer PJ. Efficacy and tolerance of antihypertensive treatment in men and women with stage 1 diastolic hypertension. Results of the Treatment of Mild Hypertension Study. Jama Internal Medicine. 156: 377-385. DOI: 10.1001/Archinte.1996.00440040047006 |
0.411 |
|
| 1996 |
Flack JM, Perez-Monagas D, Novikov S. Systolic hypertension Acc Current Journal Review. 5: 67-68. |
0.375 |
|
| 1995 |
McVeigh GE, Flack J, Grimm R. Goals of antihypertensive therapy. Drugs. 49: 161-75. PMID 7729325 DOI: 10.2165/00003495-199549020-00002 |
0.469 |
|
| 1995 |
Gardin JM, Wagenknecht LE, Anton-Culver H, Flack J, Gidding S, Kurosaki T, Wong ND, Manolio TA. Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women. The CARDIA study. Coronary Artery Risk Development in Young Adults. Circulation. 92: 380-7. PMID 7634452 DOI: 10.1161/01.Cir.92.3.380 |
0.339 |
|
| 1995 |
Flack JM, Neaton J, Grimm R, Shih J, Cutler J, Ensrud K, MacMahon S. Blood pressure and mortality among men with prior myocardial infarction. Multiple Risk Factor Intervention Trial Research Group. Circulation. 92: 2437-45. PMID 7586343 DOI: 10.1161/01.Cir.92.9.2437 |
0.385 |
|
| 1995 |
FLACK J. Individual treatment approaches in hypertension. American Journal of Hypertension. 8: 4A. DOI: 10.1016/0895-7061(95)97387-7 |
0.371 |
|
| 1994 |
Kvasnicka J, Flack JM, Grimm RH. Treatment of hypertension in the presence of coexisting medical conditions. Drugs & Aging. 4: 304-12. PMID 8019053 DOI: 10.2165/00002512-199404040-00003 |
0.418 |
|
| 1994 |
Howard BV, Le NA, Belcher JD, Flack JM, Jacobs DR, Lewis CE, Marcovina SM, Perkins LL. Concentrations of Lp(a) in black and white young adults: relations to risk factors for cardiovascular disease. Annals of Epidemiology. 4: 341-50. PMID 7981840 DOI: 10.1016/1047-2797(94)90067-1 |
0.302 |
|
| 1994 |
Abraham PA, Mascioli SR, Launer CA, Flack JM, Liebson PR, Svendsen KH, Grandits GA, Opsahl JA, Schoenberger JA, Grimm RH. Urinary albumin and N-acetyl-beta-D-glucosaminidase excretions in mild hypertension. American Journal of Hypertension. 7: 965-74. PMID 7848623 DOI: 10.1093/Ajh/7.11.965 |
0.476 |
|
| 1994 |
Flack JM. High blood pressure in older persons: a high risk special population. Canadian Journal of Public Health = Revue Canadienne De Santã© Publique. 85: S9-11. PMID 7804955 |
0.38 |
|
| 1993 |
Flack JM, Neaton JD, Daniels B, Esunge P. Ethnicity and renal disease: lessons from the Multiple Risk Factor Intervention Trial and the Treatment of Mild Hypertension Study. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 21: 31-40. PMID 8465834 DOI: 10.1016/S0272-6386(12)80859-6 |
0.468 |
|
| 1993 |
Bradley K, Flack JM, Belcher J, Elmer P, Miller P, Grimm R. Chlorthalidone attenuates the reduction in total cholesterol and small, dense LDL cholesterol subclass associated with weight loss. American Journal of Hypertension. 6: 636-9. PMID 8398006 DOI: 10.1093/Ajh/6.7.636 |
0.321 |
|
| 1993 |
Neaton JD, Grimm RH, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, Cutler JA, Flack JM, Schoenberger JA, McDonald R. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. Jama. 270: 713-24. PMID 8336373 DOI: 10.1001/Jama.1993.03510060059034 |
0.406 |
|
| 1993 |
Folsom AR, Qamhieh HT, Flack JM, Hilner JE, Liu K, Howard BV, Tracy RP. Plasma fibrinogen: levels and correlates in young adults. The Coronary Artery Risk Development in Young Adults (CARDIA) Study. American Journal of Epidemiology. 138: 1023-36. PMID 8266905 DOI: 10.1093/Oxfordjournals.Aje.A116821 |
0.329 |
|
| 1993 |
Perloff D, Grim C, Flack J, Frohlich ED, Hill M, McDonald M, Morgenstern BZ. Human blood pressure determination by sphygmomanometry. Circulation. 88: 2460-70. PMID 8222141 DOI: 10.1161/01.Cir.88.5.2460 |
0.366 |
|
| 1993 |
Flack JM, McVeigh G, Grimm RH. Hypertension therapy in the elderly. Current Opinion in Nephrology and Hypertension. 2: 386-94. PMID 7922199 |
0.303 |
|
| 1993 |
Wilt TJ, Sprinkle JW, Flack JM, Heuer C, Borhani N, Merchant A, Schnaper HW, Applegate W, Grimm RH. Prevalence and correlates of lower extremity arerial disease in hypertensive patient with carotid atherosclerosis: Baseline results from the Multicenter Isradipine/Diuretic Atherosclerosis Study (MIDAS) Journal of Vascular Medicine and Biology. 4: 95-101. |
0.345 |
|
| 1992 |
Wiist WH, Flack JM. A test of the John Henryism hypothesis: cholesterol and blood pressure. Journal of Behavioral Medicine. 15: 15-29. PMID 1605807 DOI: 10.1007/Bf00848375 |
0.432 |
|
| 1991 |
McVeigh GE, Burns DE, Finkelstein SM, McDonald KM, Mock JE, Feske W, Carlyle PF, Flack J, Grimm R, Cohn JN. Reduced vascular compliance as a marker for essential hypertension. American Journal of Hypertension. 4: 245-51. PMID 2043302 DOI: 10.1093/Ajh/4.3.245 |
0.42 |
|
| 1991 |
Folsom AR, Burke GL, Byers CL, Hutchinson RG, Heiss G, Flack JM, Jacobs DR, Caan B. Implications of obesity for cardiovascular disease in blacks: the CARDIA and ARIC studies. The American Journal of Clinical Nutrition. 53: 1604S-1611S. PMID 2031493 DOI: 10.1093/Ajcn/53.6.1604S |
0.367 |
|
| 1991 |
Mascioli S, Grimm R, Launer C, Svendsen K, Flack J, Gonzalez N, Elmer P, Neaton J. Sodium chloride raises blood pressure in normotensive subjects. The study of sodium and blood pressure. Hypertension. 17: I21-6. PMID 1987006 DOI: 10.1161/01.Hyp.17.1_Suppl.I21 |
0.446 |
|
| 1991 |
Elmer PJ, Grimm RH, Flack J, Laing B. Dietary sodium reduction for hypertension prevention and treatment. Hypertension. 17: I182-9. PMID 1987001 DOI: 10.1161/01.Hyp.17.1_Suppl.I182 |
0.338 |
|
| 1991 |
Flack JM, Ensrud KE, Mascioli S, Launer CA, Svendsen K, Elmer PJ, Grimm RH. Racial and ethnic modifiers of the salt-blood pressure response. Hypertension. 17: I115-21. PMID 1986988 DOI: 10.1161/01.Hyp.17.1_Suppl.I115 |
0.433 |
|
| 1991 |
Flack JM, Wiist WH. Epidemiology of hypertension and hypertensive target-organ damage in the United States. Journal of the Association For Academic Minority Physicians : the Official Publication of the Association For Academic Minority Physicians. 2: 143-50. PMID 1839824 |
0.394 |
|
| 1990 |
Grimm RH, Flack JM, Byington R, Bond G, Brugger S. A Comparison of Antihypertensive Drug Effects on the Progression of Extracranial Carotid Atherosclerosis: The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS) Drugs. 40: 38-43. PMID 2150640 DOI: 10.2165/00003495-199000402-00011 |
0.452 |
|
| 1989 |
Grimm RH, Flack JM. Management of hypertension. Potential trade-offs on coronary risk The American Journal of Medicine. 87. PMID 2669474 DOI: 10.1016/0002-9343(89)90116-2 |
0.379 |
|
| Show low-probability matches. |